Swedencare AB (publ)

OM:SECARE Stock Report

Market Cap: SEK 7.5b

Swedencare Valuation

Is SECARE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SECARE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SECARE (SEK47.2) is trading below our estimate of fair value (SEK142.62)

Significantly Below Fair Value: SECARE is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SECARE?

Key metric: As SECARE is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SECARE. This is calculated by dividing SECARE's market cap by their current earnings.
What is SECARE's PE Ratio?
PE Ratio120.7x
EarningsSEK 62.10m
Market CapSEK 7.50b

Price to Earnings Ratio vs Peers

How does SECARE's PE Ratio compare to its peers?

The above table shows the PE ratio for SECARE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average61.5x
CAMX Camurus
125x83.1%SEK 33.3b
MCAP MedCap
38.6xn/aSEK 8.8b
BIOG B BioGaia
33x16.6%SEK 11.1b
BIOT Biotage
49.6x19.5%SEK 12.7b
SECARE Swedencare
120.7x64.2%SEK 7.5b

Price-To-Earnings vs Peers: SECARE is expensive based on its Price-To-Earnings Ratio (120.7x) compared to the peer average (61.5x).

Price to Earnings Ratio vs Industry

How does SECARE's PE Ratio compare vs other companies in the European Pharmaceuticals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
SECARE 120.7xIndustry Avg. 19.5xNo. of Companies12PE01632486480+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SECARE is expensive based on its Price-To-Earnings Ratio (120.7x) compared to the European Pharmaceuticals industry average (19.5x).

Price to Earnings Ratio vs Fair Ratio

What is SECARE's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SECARE PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio120.7x
Fair PE Ratio83.6x

Price-To-Earnings vs Fair Ratio: SECARE is expensive based on its Price-To-Earnings Ratio (120.7x) compared to the estimated Fair Price-To-Earnings Ratio (83.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SECARE forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 47.20
SEK 58.67
+24.3%
6.6%SEK 64.00SEK 55.00n/a3
Dec ’25SEK 49.60
SEK 58.67
+18.3%
6.6%SEK 64.00SEK 55.00n/a3
Nov ’25SEK 45.78
SEK 58.67
+28.1%
6.6%SEK 64.00SEK 55.00n/a3
Oct ’25SEK 43.64
SEK 63.00
+44.4%
1.6%SEK 64.00SEK 62.00n/a2
Sep ’25SEK 40.74
SEK 63.00
+54.6%
1.6%SEK 64.00SEK 62.00n/a2
Aug ’25SEK 44.98
SEK 63.00
+40.1%
1.6%SEK 64.00SEK 62.00n/a2
Jul ’25SEK 59.00
SEK 67.00
+13.6%
4.5%SEK 70.00SEK 64.00n/a2
Jun ’25SEK 59.20
SEK 67.00
+13.2%
4.5%SEK 70.00SEK 64.00n/a2
May ’25SEK 56.60
SEK 67.00
+18.4%
4.5%SEK 70.00SEK 64.00n/a2
Apr ’25SEK 63.94
SEK 68.00
+6.3%
5.9%SEK 72.00SEK 64.00n/a2
Mar ’25SEK 55.10
SEK 68.00
+23.4%
5.9%SEK 72.00SEK 64.00n/a2
Feb ’25SEK 62.18
SEK 59.50
-4.3%
7.6%SEK 64.00SEK 55.00n/a2
Jan ’25SEK 60.96
SEK 50.00
-18.0%
10.0%SEK 55.00SEK 45.00n/a2
Dec ’24SEK 58.92
SEK 50.00
-15.1%
10.0%SEK 55.00SEK 45.00SEK 49.602
Nov ’24SEK 44.00
SEK 50.00
+13.6%
10.0%SEK 55.00SEK 45.00SEK 45.782
Oct ’24SEK 40.86
SEK 49.50
+21.1%
9.1%SEK 54.00SEK 45.00SEK 43.642
Sep ’24SEK 46.90
SEK 49.50
+5.5%
9.1%SEK 54.00SEK 45.00SEK 40.742
Aug ’24SEK 46.07
SEK 44.50
-3.4%
21.3%SEK 54.00SEK 35.00SEK 44.982
Jul ’24SEK 38.01
SEK 44.50
+17.1%
21.3%SEK 54.00SEK 35.00SEK 59.002
Jun ’24SEK 44.40
SEK 44.50
+0.2%
21.3%SEK 54.00SEK 35.00SEK 59.202
May ’24SEK 32.60
SEK 42.00
+28.8%
31.0%SEK 55.00SEK 29.00SEK 56.602
Apr ’24SEK 25.47
SEK 47.50
+86.5%
26.3%SEK 60.00SEK 35.00SEK 63.942
Mar ’24SEK 26.74
SEK 47.25
+76.7%
27.0%SEK 60.00SEK 34.50SEK 55.102
Feb ’24SEK 36.28
SEK 54.75
+50.9%
37.0%SEK 75.00SEK 34.50SEK 62.182
Jan ’24SEK 30.75
SEK 58.00
+88.6%
29.3%SEK 75.00SEK 41.00SEK 60.962
Dec ’23SEK 34.88
SEK 58.00
+66.3%
29.3%SEK 75.00SEK 41.00SEK 58.922

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 02:49
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Swedencare AB (publ) is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Johan BrownABG Sundal Collier Sponsored
Martin ComtesseJefferies LLC
Adrian ElmlundNordea Markets